Summary of Study ST002891

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001804. The data can be accessed directly via it's Project DOI: 10.21228/M8HX5R This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Show all samples  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST002891
Study TitleGlutamine metabolism improves left ventricular function but not macrophage-mediated inflammation following myocardial infarction
Study Typeuntargeted metabolomics analysis
Study SummaryGlutamine is a critical amino acid that serves as an energy source, building block, and signaling molecule for both the heart tissue and the immune system. However, the role of glutamine metabolism in regulating cardiac remodeling following myocardial infarction (MI) is unknown. In this study, we show that glutamine metabolism is altered both in the remote (contractile) area and in infiltrating macrophages in the infarct area after MI in adult male mice by permanent left anterior descending artery occlusion. Using untargeted metabolomics in extracted LV macrophages, we found that metabolites related to glutamine metabolism were differentially altered at days 1, 3, and 7 after MI. Glutamine metabolism in live cells was found to be increased after MI relative to no MI controls. Gene expression in the remote area of the heart indicated a loss of glutamine metabolism. Glutamine administration improved LV function at days 1, 3, and 7, which was associated with improved contractile and metabolic gene expression.
Institute
Vanderbilt University
DepartmentChemistry
LaboratoryCenter for Innovative Technology
Last NameCodreanu
First NameSimona
Address1234 STEVENSON CENTER LANE, NASHVILLE, TN, 37235, USA
EmailSIMONA.CODREANU@VANDERBILT.EDU
Phone6158758422
Submit Date2023-09-29
Raw Data AvailableYes
Raw Data File Type(s)raw(Thermo)
Analysis Type DetailLC-MS
Release Date2024-04-02
Release Version1
Simona Codreanu Simona Codreanu
https://dx.doi.org/10.21228/M8HX5R
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Combined analysis:

Analysis ID AN004750
Analysis type MS
Chromatography type HILIC
Chromatography system Vanquish UHPLC
Column ACQUITY UPLC BEH Amide HILIC
MS Type ESI
MS instrument type Orbitrap
MS instrument name Thermo Q Exactive HF hybrid Orbitrap
Ion Mode NEGATIVE
Units time_m/z

Chromatography:

Chromatography ID:CH003582
Chromatography Summary:Metabolite extracts were separated on ACQUITY UPLC BEH Amide HILIC 1.7 μm, 2.1 × 100 mm column (Waters Corporation, Milford, MA) held at 30°C. Liquid chromatography was performed at a 200 μL min using solvent A (5 mM Ammonium formate in 90% water, 10% acetonitrile, and 0.1% formic acid) and solvent B (5 mM Ammonium formate in 90% acetonitrile, 10% water, and 0.1% formic acid) with a gradient length of 30 min.
Instrument Name:Vanquish UHPLC
Column Name:ACQUITY UPLC BEH Amide HILIC
Column Temperature:30
Flow Gradient:Linear gradient of 30 min
Flow Rate:0.20mL/min
Solvent A:90% water/10% acetonitrile; 5mM ammonium formate; 0.1% formic acid
Solvent B:10% water/90% acetonitrile; 5mM ammonium formate; 0.1% formic acid
Chromatography Type:HILIC
  logo